BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20523902)

  • 1. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.
    Ilyushina NA; Seiler JP; Rehg JE; Webster RG; Govorkova EA
    PLoS Pathog; 2010 May; 6(5):e1000933. PubMed ID: 20523902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.
    Govorkova EA; Ilyushina NA; Marathe BM; McClaren JL; Webster RG
    J Virol; 2010 Aug; 84(16):8042-50. PubMed ID: 20519385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
    Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA
    J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.
    Kiso M; Ozawa M; Le MT; Imai H; Takahashi K; Kakugawa S; Noda T; Horimoto T; Kawaoka Y
    J Virol; 2011 May; 85(10):4667-72. PubMed ID: 21367898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
    Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK
    J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitors susceptibility profiles of highly pathogenic influenza A (H5N1) viruses isolated from avian species in India (2006-2015).
    Sood R; Kumar N; Bhatia S; Chanu KV; Gupta CL; Pateriya AK; Mishra A; Khandia R; Mawale N; Singh VP
    Antiviral Res; 2018 Oct; 158():143-146. PubMed ID: 30125616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.
    Ilyushina NA; Govorkova EA; Gray TE; Bovin NV; Webster RG
    PLoS Pathog; 2008 Apr; 4(4):e1000043. PubMed ID: 18404209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of influenza H1N1 neuraminidase V116A and I117V mutations on NA activity and sensitivity to NA inhibitors.
    Adams SE; Lee N; Lugovtsev VY; Kan A; Donnelly RP; Ilyushina NA
    Antiviral Res; 2019 Sep; 169():104539. PubMed ID: 31228489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
    Hurt AC; Lowther S; Middleton D; Barr IG
    Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivir.
    Kode SS; Pawar SD; Tare DS; Keng SS; Hurt AC; Mullick J
    Vet Microbiol; 2019 Aug; 235():21-24. PubMed ID: 31282375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
    J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.
    Burnham AJ; Baranovich T; Marathe BM; Armstrong J; Webster RG; Govorkova EA
    Antimicrob Agents Chemother; 2014 May; 58(5):2718-30. PubMed ID: 24566185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.
    Govorkova EA; Baranovich T; Seiler P; Armstrong J; Burnham A; Guan Y; Peiris M; Webby RJ; Webster RG
    Antiviral Res; 2013 May; 98(2):297-304. PubMed ID: 23458714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
    Abed Y; Baz M; Boivin G
    Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Abed Y; Nehmé B; Baz M; Boivin G
    Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.
    Pascua PN; Marathe BM; Burnham AJ; Vogel P; Webby RJ; Webster RG; Govorkova EA
    PLoS One; 2016; 11(7):e0159847. PubMed ID: 27466813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.